Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2768594rdf:typepubmed:Citationlld:pubmed
pubmed-article:2768594lifeskim:mentionsumls-concept:C0030326lld:lifeskim
pubmed-article:2768594lifeskim:mentionsumls-concept:C1302234lld:lifeskim
pubmed-article:2768594pubmed:issue3lld:pubmed
pubmed-article:2768594pubmed:dateCreated1989-9-26lld:pubmed
pubmed-article:2768594pubmed:abstractTextTwo patients with benign cytophagic histiocytic panniculitis are presented and compared with the one benign and ten fatal cases previously reported. Benign-appearing histiocytes which engulf blood cells, nuclear debris, and platelets are the most characteristic feature of the disease. This cytophagia tends to be massive in the subcutaneous tissue and involves extracutaneous organs only in the fatal cases. The course is chronic in the benign form. Patients with the fatal form tend to have fever, hepatosplenomegaly, serosal effusions, ecchymoses, peripheral adenopathy, and mucosal ulcers. Anemia, leukopenia, elevated liver enzyme levels, and coagulopathy are present in almost all and hypocalcemia in many patients with a fatal course. Cytophagic histiocytic panniculitis may represent a form of regional histiocytosis primarily involving subcutaneous tissue. It is midway in the spectrum of the cytophagic histiocytoses.lld:pubmed
pubmed-article:2768594pubmed:languageenglld:pubmed
pubmed-article:2768594pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2768594pubmed:citationSubsetIMlld:pubmed
pubmed-article:2768594pubmed:statusMEDLINElld:pubmed
pubmed-article:2768594pubmed:monthJunlld:pubmed
pubmed-article:2768594pubmed:issn0303-6987lld:pubmed
pubmed-article:2768594pubmed:authorpubmed-author:WinkelmannR...lld:pubmed
pubmed-article:2768594pubmed:authorpubmed-author:WhiteJ WJWJrlld:pubmed
pubmed-article:2768594pubmed:issnTypePrintlld:pubmed
pubmed-article:2768594pubmed:volume16lld:pubmed
pubmed-article:2768594pubmed:ownerNLMlld:pubmed
pubmed-article:2768594pubmed:authorsCompleteYlld:pubmed
pubmed-article:2768594pubmed:pagination137-44lld:pubmed
pubmed-article:2768594pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2768594pubmed:meshHeadingpubmed-meshheading:2768594-...lld:pubmed
pubmed-article:2768594pubmed:meshHeadingpubmed-meshheading:2768594-...lld:pubmed
pubmed-article:2768594pubmed:meshHeadingpubmed-meshheading:2768594-...lld:pubmed
pubmed-article:2768594pubmed:meshHeadingpubmed-meshheading:2768594-...lld:pubmed
pubmed-article:2768594pubmed:meshHeadingpubmed-meshheading:2768594-...lld:pubmed
pubmed-article:2768594pubmed:meshHeadingpubmed-meshheading:2768594-...lld:pubmed
pubmed-article:2768594pubmed:meshHeadingpubmed-meshheading:2768594-...lld:pubmed
pubmed-article:2768594pubmed:meshHeadingpubmed-meshheading:2768594-...lld:pubmed
pubmed-article:2768594pubmed:year1989lld:pubmed
pubmed-article:2768594pubmed:articleTitleCytophagic histiocytic panniculitis is not always fatal.lld:pubmed
pubmed-article:2768594pubmed:affiliationDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota.lld:pubmed
pubmed-article:2768594pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2768594pubmed:publicationTypeCase Reportslld:pubmed